Literature DB >> 15905150

CFTR in cystic fibrosis and cholera: from membrane transport to clinical practice.

Barbara E Goodman1, William H Percy.   

Abstract

We have used a brief analysis of transport via cystic fibrosis (CF) transmembrane conductance regulators (CFTRs) in various organ systems to highlight the importance of basic membrane transport processes across epithelial cells for first-year medical students in physiology. Because CFTRs are involved in transport both physiologically and pathologically in various systems, we have used this clinical correlation to analyze how a defective gene leading to defective transport proteins can be directly involved in the symptoms of cholera and CF. This article is a "Staying Current" approach to transport via CFTRs including numerous helpful references with further information for a teaching faculty member. The article follows our normal presentation which begins with a discussion of the involvement of CFTR transport in the intestine and how cholera affects intestinal transport, extends to CFTR transport in various organ systems in CF, and concludes with the logic behind many of the treatments that improve CF. Student learning objectives are included to assist in assessment of student understanding of the basic concepts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905150     DOI: 10.1152/advan.00035.2004

Source DB:  PubMed          Journal:  Adv Physiol Educ        ISSN: 1043-4046            Impact factor:   2.288


  10 in total

1.  Ultrastructural changes in the Meissner plexus of the suckling rabbit small intestine in experimental cholera.

Authors:  E A Bardakhchian; Yu M Lomov; N G Kharlanova
Journal:  Dokl Biol Sci       Date:  2011-01-18

Review 2.  Engineering microbes for targeted strikes against human pathogens.

Authors:  In Young Hwang; Hui Ling Lee; James Guoxian Huang; Yvonne Yijuan Lim; Wen Shan Yew; Yung Seng Lee; Matthew Wook Chang
Journal:  Cell Mol Life Sci       Date:  2018-05-07       Impact factor: 9.261

Review 3.  Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?

Authors:  E K Schneider; F Reyes-Ortega; J Li; T Velkov
Journal:  Clin Pharmacol Ther       Date:  2016-11-23       Impact factor: 6.875

Review 4.  Beyond cystic fibrosis transmembrane conductance regulator therapy: a perspective on gene therapy and small molecule treatment for cystic fibrosis.

Authors:  Elena K Schneider-Futschik
Journal:  Gene Ther       Date:  2019-07-12       Impact factor: 5.250

Review 5.  Rescue of folding defects in ABC transporters using pharmacological chaperones.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Bioenerg Biomembr       Date:  2005-12       Impact factor: 3.853

Review 6.  The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability.

Authors:  Xin Meng; Jack Clews; Vasileios Kargas; Xiaomeng Wang; Robert C Ford
Journal:  Cell Mol Life Sci       Date:  2016-10-12       Impact factor: 9.261

Review 7.  Sweating Rate and Sweat Sodium Concentration in Athletes: A Review of Methodology and Intra/Interindividual Variability.

Authors:  Lindsay B Baker
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

Review 8.  Physiology of sweat gland function: The roles of sweating and sweat composition in human health.

Authors:  Lindsay B Baker
Journal:  Temperature (Austin)       Date:  2019-07-17

Review 9.  Physiological mechanisms determining eccrine sweat composition.

Authors:  Lindsay B Baker; Anthony S Wolfe
Journal:  Eur J Appl Physiol       Date:  2020-03-02       Impact factor: 3.078

Review 10.  Advances in Ca2+ modulation of gastrointestinal anion secretion and its dysregulation in digestive disorders (Review).

Authors:  Weixi Shan; Yanxia Hu; Jianhong Ding; Xiaoxu Yang; Jun Lou; Qian Du; Qiushi Liao; Lihong Luo; Jingyu Xu; Rui Xie
Journal:  Exp Ther Med       Date:  2020-08-25       Impact factor: 2.447

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.